Title: Mesenchymal stem cell transplantation in limbal stem cell deficiency - Development of precision medicine
Abstract: Limbal stem cell deficiency (LSCD) causes discomfort and reduced vision and is a major problem in ophthalmology. Today, the treatment is transplantation of allogenic limbal stem cells, but this has its limitations.
Mesenchymal stem cells are now emerging as a promising treatment option. The phase 1 clinical trial using these cells in patients with end-stage LSCD will be presented.
About the speaker: Cecilie Bredrup is an Ophthalmologist at Haukeland University Hospital and an associate professor at University of Bergen. She did her PhD in 2009 in Bergen, with the thesis "Clinical and molecular aspects of congenital hereditary eye disease".
More about Dr Bredrup's work here.
One of the four core projects of MRCRM is led by Dr Bredrup. More about the project here.